课题基金 / 基金详情

Characterization of a new "intracellular immunization" strategy restricting HIV-1 infection and inducing host immune response

Characterization of a new "intracellular immunization" strategy restricting HIV-1 infection and inducing host immune response
限制 HIV-1 感染并诱导宿主免疫反应的新“细胞内免疫”策略的表征
批准号:
297414
负责人:
Yao Xiao-Jian
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2014-09-01

项目摘要

项目成果

Yao Xiao-Jian的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
APOBEC3G (A3G), a deoxycytidine deaminase, is a powerful host antiviral factor that is able to restrict HIV infection by causing virus hypermutations. Moreover, A3G was also shown to act as an inducer of the adaptive immune response. However, during a wi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a multivalent rVSV vaccine against different Chlamydia trachomatis urogenital infections
  • 批准号:
    488750
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.78万
  • 财政年份:
    2023
  • 负责人:
    Yao Xiao-Jian
  • 依托单位:
COVID-19 Variant Supplement - Development of a novel DC-targeting vaccine that targets COVID-19 spike protein to control COVID-19 infection
  • 批准号:
    443196
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Yao Xiao-Jian
  • 依托单位:
Development of a novel DC-targeting vaccine that targets COVID-19 spike protein to control COVID-19 infection
  • 批准号:
    422759
  • 项目类别:
    Operating Grants
  • 资助金额:
    $23.79万
  • 财政年份:
    2020
  • 负责人:
    Yao Xiao-Jian
  • 依托单位:
Contribution of Dynein light chain-1 for efficient HIV-1 reverse transcription and the underlying molecular mechanisms
  • 批准号:
    287160
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2013
  • 负责人:
    Yao Xiao-Jian
  • 依托单位:
海外基金